Inhibition of firefly luciferase activity by a HIF prolyl hydroxylase inhibitor
{{output}}
The three hypoxia-inducible factor (HIF) prolyl-4-hydroxylase domain (PHD) 1-3 enzymes confer oxygen sensitivity to the HIF pathway and are novel therapeutic targets for treatment of renal anemia. Inhibition of the PHDs may further be beneficial in other hypox... ...
